mycotoxins: analytical challenges

Mycotoxins: Analytical Challenges

Mycotoxins are natural secondary fungal metabolites produced on agricultural commodities. Mould and mycotoxin contamination may occur before harvesting, between harvesting and drying, and during storage. FAO has estimated that approximately 25% of the world's crops are contaminated by molds and affected by mycotoxins, and the estimated loss extends to billions of dollars. Since fungi have a wid...

Challenges in risk assessment of multiple mycotoxins in food

Most fungi are able to produce several mycotoxins simultaneously and, consequently, to contaminate a wide variety of foodstuffs. Therefore, the risk of human co-exposure to multiple mycotoxins is real, raising a growing concern about their potential impact on human health. Besides, government and industry regulations are usually based on individual toxicities, and do not take into account the c...

Mycotoxins in Food and Agriculture-Challenges and Opportunities

Mycotoxins.

INTRODUCTION .......................................................................................................................................................497 Mycoses and Mycotoxicoses ..................................................................................................................................497 Definitions, Etymology, and General Principles..........................

The analytical challenges of anti-doping analysis.

The development of new anti-doping analyses presents a fascinating and ever-changing set of bioanalytical challenges to those who endeavor to devise tests to detect prohibited substances used by athletes. Perhaps unlike any other field of analysis, anti-doping analysis is one with a constantly moving target; as new analyses are developed, new doping techniquesmove to the forefront. This “arms r...

Analytical and Experimental Pharmacology, Challenges Ahead

Everybody would agree in saying that advances in Medicine, in the last decades, have lead to significant increase in life expectancy. However, the direct impact of global drug development might be harder to be precisely defined. Let then consider the following example. In the years between 1990 and 1994 AIDS was the first cause of death among people <45 in USA, with up to 40 deaths/year/100,000...